2021
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
Vrachatis DA, Papathanasiou KA, Iliodromitis KE, Giotaki SG, Kossyvakis C, Raisakis K, Kaoukis A, Lambadiari V, Avramides D, Reimers B, Stefanini GG, Cleman M, Giannopoulos G, Lansky A, Deftereos SG. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations. Drugs 2021, 81: 1381-1395. PMID: 34297330, DOI: 10.1007/s40265-021-01565-3.Peer-Reviewed Original ResearchConceptsAtrial fibrillationSGLT2 inhibitorsCardiorenal protectionAntiarrhythmic effectsClinical dataSodium/glucose co-transporter-2 inhibitorClinical data implyDate available evidenceGlucose-lowering medicationsEffective therapeutic optionPotential pathophysiological linkLarge clinical trialsPre-specified endpointsType 2 diabetesPossible beneficial effectsPost Hoc AnalysisNormoglycemic adultsAF burdenAF preventionPathophysiologic mechanismsPathophysiological linkSGLT2 inhibitionAntiarrhythmic potentialSodium glucoseTherapeutic options
2020
Computerised Methodologies for Non‐Invasive Angiography‐Derived Fractional Flow Reserve Assessment: A Critical Review
Ramasamy A, Jin C, Tufaro V, Bajaj R, Kilic Y, Safi H, Amersey R, Jones D, Torii R, Lansky A, Mathur A, Bourantas CV, Baumbach A. Computerised Methodologies for Non‐Invasive Angiography‐Derived Fractional Flow Reserve Assessment: A Critical Review. Journal Of Interventional Cardiology 2020, 2020: 6381637. PMID: 32395091, PMCID: PMC7189319, DOI: 10.1155/2020/6381637.Peer-Reviewed Original Research
2005
Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. The American Journal Of Cardiology 2005, 95: 13-19. PMID: 15619387, DOI: 10.1016/j.amjcard.2004.08.056.Peer-Reviewed Original ResearchConceptsContrast-induced nephropathyChronic kidney diseasePercutaneous coronary interventionIntra-aortic balloon pump useCoronary interventionKidney diseasePump usePredictors of CINPresence of CKDBaseline chronic kidney diseaseLower baseline hematocritBaseline renal functionContrast medium volumeHospital complicationsPeriprocedural hypotensionHospital stayBaseline characteristicsRenal functionConsecutive patientsEjection fractionBaseline hematocritPulmonary edemaHemodynamic variablesHemodynamic parametersPatients
2000
Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization
Dangas G, Mintz G, Mehran R, Ahmed J, Lansky A, Pichard A, Satler L, Kent K, Stone G, Leon M. Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization. The American Journal Of Cardiology 2000, 86: 452-455. PMID: 10946042, DOI: 10.1016/s0002-9149(00)00964-4.Peer-Reviewed Original Research